Conmed (CNMD) came out with quarterly earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.51%. A quarter ago, it was expected that this medical technology company would post earnings of $0.83 per share when it actually produced earnings of $0.90, delivering a surprise of 8.43%.Over the last four quarters, the ...

2024 Financial Guidance Revenue $1.340 B to $1.365 B, ~8% to ~10% growth Q1: ~3% to ~5% growth* Q2: Mid-to-high-single-digit growth Adjusted SG&A Expense 60 to 80 basis point improvement as a percent of sales Q4 2023 Earnings Call 10 Environmental Social Governance | --- | --- | --- | --- | --- | |-------|--------------------------------------------------|------------------------------------------------------------------------------|-------|------------------------------------------------------------------- ...

Key PointsCONMED shares dove 10% last week, retreating below the $100.00 level in an apparent bout of profit taking on one of the market’s hottest groups.The company is expected to have generated approximately $332 million in fourth quarter sales with EPS forecast to jump 164% year-over-year to $1.11.Even if the "Ozempic effect" is large, it will likely have an insignificant impact on CONMED’s overall financial results since the company provides products for many procedures other than bariatric surgery.5 st ...

Wall Street analysts expect Conmed (CNMD) to post quarterly earnings of $1.11 per share in its upcoming report, which indicates a year-over-year increase of 164.3%. Revenues are expected to be $332.94 million, up 32.7% from the year-ago quarter.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company announces its e ...

CONMED Corporation (NYSE:CNMD) Q3 2023 Earnings Conference Call October 25, 2023 4:30 PM ET Company Participants Curt Hartman – President and Chief Executive Officer Todd Garner – Executive Vice President and Chief Financial Officer Conference Call Participants Vik Chopra – Wells Fargo Robbie Marcus – J.P. Morgan Rick Wise – Stifel Matt O’Brien – Piper Sandler Kristen Stewart – CL King Carolyn Huszagh – Bank of America Operator Thank you for standing by. And welcome to CONMED’s Q3 Fiscal Year 2023 Earnings ...

Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer October 25, 2023 This presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forwardlooking statements herein or in previous disclosures. For example, in addition to general industr ...

Selling and Administrative Expense Table of Contents Operating cash flows things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions. We were in full compliance with these covenants and restrictions as of September 30, 2023. We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales. I ...

CONMED Corporation (NYSE:CNMD) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ET Company Participants Curt Hartman - Chairman, President, and CEO Todd Garner - EVP and CFO Conference Call Participants Robert Marcus - JPMorgan Rick Wise - Stifel Matthew O'Brien - Piper Sandler Vik Chopra - Wells Fargo Matthew Mishan - KeyBanc Young Li - Jefferies Kristen Stewart - C.L. King Mike Matson - Needham & Company Operator Before the conference call begins, let me remind you that during this call, management ...

Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer July 26, 2023 in the power of engaged talent. ℃CONMED | Q2 2023 Earnings Call • Evolve product mix toward higher-growth, higher-margin offerings Q2 2023 Earnings Call | --- | --- | --- | --- | --- | --- | --- | |--------------------------------|---------------|-------------------------------|---------------------------------------------------------------------------- ...

Washington, D.C. 20549 Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File re ...